Peer Review History

Original SubmissionMay 16, 2021
Decision Letter - Seyed Ehtesham Hasnain, Editor

PONE-D-21-15501

Are neighborhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding in Bandung, Indonesia

PLOS ONE

Dear Dr. Koesoemadinata,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Seyed Ehtesham Hasnain

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please upload a copy of Figure 2 and 3, to which you refer in your text on pages 6 and 7. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Minor revision

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have worked on the protocol in finding the active tuberculosis cases in their neighborhoods of Bandung from Indonesia. The study measures the TB prevalence and incidence in households and neighborhoods in the vicinity of known TB cases, and to assess how genomic and epidemiological relatedness varies between TB cases from household contacts, and those from the neighborhoods. The manuscript is well designed; statistics and other analyses are performed to a high technical standard and are described in sufficient detail. Conclusions needs to be supported by the data.

Comments

1. As you have not excluded the comorbidity, did you studied what is the prevalence and incidence rate in households or neighborhoods, who have comorbidity.

2. According to prevalence neighborhoods have higher incidence rate than households, whereas genomical identity is lower in neighborhoods than households. Can you explain these and how did you find these differences?

3. What is the percentage of drop outs during the follow up in your study ?

4. No data has been generated or analyzed in the current study. You have mentioned SNA analysis, it will be more informative if you can add those images.

5. Discussion and conclusion of the study is not informative, it is poorly structured due to lack of previous studies or citations in the neighborhood. It is better to rewrite to understand easily.

6. Correct the grammatical mistakes in the manuscript.

.

Reviewer #2: Comments:

Presented study protocol may help in the findings to measure TB prevalence and incidence in household contacts as well as neighborhoods in the surrounding area of known TB cases from our society. It has been written very nicely, however few advices may improve this protocol:

• While collecting the data of socio-demographic information, author may take collect the common TB comorbidities include diabetes mellitus, smoking, alcohol-use disorders, chronic lung diseases, cancer and depression data also.

• In patient history, alcoholism and smoker status of patient as well as neighborhoods contact should be noted if possible. Because these behavior are strongly associated with TB disease and attributed to high risk of SARs in elderly and TB comorbidities patients.

• It is also advised to perform phenotypic DST to all culture positive specimens in addition of genotypic DST.

• EPTB is already excluded from this study. However, it is also advised to make a separate group for them to analyzed data considering all methodology as discussed.

Conclusion: Authors are advised to reframe.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

22 July 2021

Seyed Ehtesham Hasnain

Academic Editor

PLOS ONE

Dear Dr Hasnain,

Re: Manuscript PONE-D-21-15501: “Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding in Bandung, Indonesia”

Thank you for review of the above-stated manuscript and the opportunity to submit a revised version.

The two reviewers made helpful suggestions for improvement which we believe we have addressed in the revised paper or in our rebuttal below. We have responded to each point raised by the reviewers and have updated the manuscript, indicated as track changes.

Thank you for your consideration

Kind regards

Raspati C. Koesoemadinata

(Corresponding author)

Response to Reviewers

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Thank you. We have revised the manuscript, and we believe it complies with PLOS ONE's style requirements.

2. Please upload a copy of Figure 2 and 3, to which you refer in your text on pages 6 and 7. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

Figures 2 and 3 were uploaded with the original submission. We will upload them again with this revised submission to make sure they are accessible to the reviewers.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

We uploaded the research grant review and ethical approval letters and mistakenly labelled them as "Supporting information". They are now labelled as “Other”.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

The reference list has been checked. No changes have been made to the reference list.

Reviewer’s Comments to the Author

Reviewer #1: The authors have worked on the protocol in finding the active tuberculosis cases in their neighbourhoods of Bandung from Indonesia. The study measures the TB prevalence and incidence in households and neighbourhoods in the vicinity of known TB cases, and to assess how genomic and epidemiological relatedness varies between TB cases from household contacts, and those from the neighbourhoods. The manuscript is well designed; statistics and other analyses are performed to a high technical standard and are described in sufficient detail. Conclusions needs to be supported by the data.

Comments

1. As you have not excluded the comorbidity, did you studied what is the prevalence and incidence rate in households or neighbourhoods, who have comorbidity.

We will ask the participants about any other immunocompromised medical conditions. This information has now been added to the manuscript (lines 129-130).

2. According to prevalence neighbourhoods have higher incidence rate than households, whereas genomical identity is lower in neighbourhoods than households. Can you explain these and how did you find these differences?

In the earlier study in Bandung, we have found a higher TB incidence rate in the neighbourhoods. This study has shown us that the incidence rate of self-reported TB was 649 per 100,000/year in TB household contacts, 675 in neighbouring households, and 325 in a randomly selected community (Reference #8). Evidence from other studies also have reported the higher TB incidence in the community outside TB households (Reference #5) (Lines 54-55). We are unsure of the genomic identity of cases in households and neighbourhoods, hence the need for this study.

3. What is the percentage of drop outs during the follow up in your study?

Several measures have been put in place to minimise drop-out, such as regular phone calls to participants throughout the 12 months, having phone numbers of other household members (Lines 146-156). The estimated percentage of drop-out that may occur during the follow-up period is not known particularly during this time of the COVID-19 pandemic. This limitation has been added to the discussion (lines 300-303).

4. No data has been generated or analyzed in the current study. You have mentioned SNA analysis, it will be more informative if you can add those images.

Our manuscript is a protocol paper. Recruitment of participants has only recently started. Full results, including SNA analysis figures will be included in the future manuscripts.

5. Discussion and conclusion of the study is not informative; it is poorly structured due to lack of previous studies or citations in the neighbourhood. It is better to rewrite to understand easily.

As our manuscript is a protocol paper, it is impossible to format it according to the standard formatting of a discussion with results. We believe we have included information required by the journal in discussing the possible implications of our study and how the results might be used. Extra information has been added on limitations.

6. Correct the grammatical mistakes in the manuscript.

Thank you. We have reviewed the manuscript thoroughly and corrected the mistakes.

Reviewer #2: Comments:

Presented study protocol may help in the findings to measure TB prevalence and incidence in household contacts as well as neighbourhoods in the surrounding area of known TB cases from our society. It has been written very nicely; however few advices may improve this protocol:

1. While collecting the data of socio-demographic information, author may take collect the common TB comorbidities include diabetes mellitus, smoking, alcohol-use disorders, chronic lung diseases, cancer and depression data also.

Thank you. Yes, questions about comorbidities, other TB risk related conditions including smoking status, are included in the questionnaire. This information has now been added to the manuscript for clarity (lines 129-130). We have found a very low prevalence of alcohol use (<2%) in our previous study therefore questions about alcohol use were not included in the current study.

2. In patient history, alcoholism and smoker status of patient as well as neighbourhoods contact should be noted if possible. Because these behavior are strongly associated with TB disease and attributed to high risk of SARs in elderly and TB comorbidities patients.

Thank you. Please see the above response

3. It is also advised to perform phenotypic DST to all culture positive specimens in addition of genotypic DST.

We don’t consider that phenotypic DST is necessary for this study and its objectives. Moreover, it would increase the costs of the study beyond the budget allocated. Therefore, we will not include it in our study.

4. EPTB is already excluded from this study. However, it is also advised to make a separate group for them to analyzed data considering all methodology as discussed.

Thank you for your suggestion. Yes, we will not include EPTB patients as the index case. However, we will record all EPTB cases found during the household or the neighbourhood screening and report them in the results (Lines 105-106).

Conclusion: Authors are advised to reframe.

It is unclear what the reviewer is asking. As this is a protocol paper, a conclusion is not a requirement according to the manuscript guidelines.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Seyed Ehtesham Hasnain, Editor

Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding

PONE-D-21-15501R1

Dear Dr. Koesoemadinata,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Seyed Ehtesham Hasnain

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

I have gone through the revised manuscript and also the Authors response to the comments of the reviewers. The manuscript was sent for revision and Authors have modified the manuscript keeping in mind the comments of the Reviewers. The important issue of co-morbidity has been addressed along with dropouts and incidence rates. Their response about phenotypic DST is acceptable.All grammatical and typographic errors have been taken care off by the Authors. In my view, the authors have otherwise satisfactorily addressed all the comments made by the reviewers and added all required information, and have revised the manuscript accordingly. I recommend this manuscript for publication.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Seyed Ehtesham Hasnain, Editor

PONE-D-21-15501R1

Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding

Dear Dr. Koesoemadinata:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Seyed Ehtesham Hasnain

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .